What is Dyshidrotic Eczema? Complete Treatment Guide

What is Dyshidrotic Eczema? Complete Treatment Guide
By Lisa Jensen, Senior Clinical Research Associate •

For up to one in five people with hand eczema, the condition will develop into small, intensely itchy blisters that disrupt their daily lives[1]. That's millions of people struggling with a condition called dyshidrotic eczema, cycling through treatments that provide only temporary relief. The good news? Recent advances in understanding this unique form of eczema have opened new treatment possibilities.

You've likely tried topical steroids, heavy moisturizers, and maybe even phototherapy. Each promised improvement, yet the blisters keep returning. In fact, studies on chronic hand eczema reveal high rates of patient dissatisfaction with conventional therapies due to limited effectiveness and side effects[2]. You know the frustration of avoiding handshakes, hiding your hands, and canceling activities because of painful blisters. You're not imagining how difficult this is.

Here's what we'll explore: the science behind those mysterious blisters, why they form specifically on your hands and feet, and evidence-based treatments that address root causes. Research indicates that targeted therapeutic approaches can improve outcomes by up to 75% in previously treatment-resistant cases[3]. You'll also learn about identifying your personal triggers to prevent future flares. We'll separate fact from speculation, giving you the knowledge to make informed treatment decisions.

A groundbreaking 2023 study revealed that dyshidrotic eczema involves unique inflammatory pathways different from other eczema types, explaining why standard treatments often fail[4]. This discovery is changing how we approach treatment.

Key Takeaways

  • Dyshidrotic eczema affects 5-20% of all hand eczema cases[1] - making it more common than many realize
  • Metal allergies trigger flares in up to 30% of patients[23] - particularly nickel and cobalt exposure
  • The condition follows a predictable three-stage pattern[17] - understanding stages helps optimize treatment timing
  • Stress management reduces flare frequency by 40%[26] - emotional triggers are as important as physical ones
  • New treatments target the skin microbiome[44] - offering hope for those who haven't responded to traditional therapies

Table of Contents

What is Dyshidrotic Eczema?

Dyshidrotic eczema is a chronic inflammatory skin condition that causes small, intensely itchy blisters on your palms, fingers, and soles of your feet. You might also hear it called pompholyx or vesicular eczema. It affects approximately 5-20% of people with hand eczema[1]. Here's what makes it different: unlike other forms of eczema, these blisters form deep within your skin rather than on the surface.

The name "dyshidrotic" comes from Greek words meaning "difficult sweating." For decades, doctors believed blocked sweat glands caused the condition. They were wrong. We now know the blisters result from spongiosis, a specific type of inflammation that causes fluid to accumulate between skin cells[6]. This discovery changed how we approach treatment.

If you're between 20 and 40, you're in the highest-risk group[7]. Women develop dyshidrotic eczema twice as often as men[8]. And if eczema runs in your family? You're more likely to develop it yourself. About 50% of patients have a personal or family history of atopic dermatitis[9].

Anatomical diagram showing dyshidrotic eczema affecting hands and feet with labeled areas

What makes dyshidrotic eczema so frustrating? Its unpredictability. A flare can last 3-4 weeks, then disappear for months[10]. Just when you think you've got it under control, it returns. Some people notice seasonal patterns, with worse symptoms during spring and summer when humidity climbs[11]. If water exposure worsens your symptoms, see our guide on swimming and eczema for practical tips.

Clinical Insight: Recent studies using advanced imaging techniques have revealed that dyshidrotic eczema involves deeper skin layers than previously thought, explaining why surface treatments alone often fail[12].

Recognizing the Signs: Symptoms and Stages

Here's something most people don't realize: your body often warns you before blisters appear. Learning to read these signals can change everything. Early treatment dramatically reduces how long flares last and how severe they get. The condition follows a predictable pattern, and once you understand it, you gain a real advantage.

Early Warning Signs

Before visible blisters appear, many people experience prodromal symptoms. These early warning signs occur 24-48 hours before blister formation[13]:

  • Intense itching or burning in specific areas of palms or soles
  • Tingling sensations under the skin
  • Mild redness in areas where blisters will form

Why does catching these early signs matter so much? Because acting fast works. Studies show that early intervention with high-potency topical corticosteroids significantly cuts both severity and duration of a flare[14]. Miss this window, and you're in for a longer ride.

Active Flare Symptoms

Once a flare takes hold, symptoms intensify quickly. This is when dyshidrotic eczema becomes truly disruptive:

Intense Itching

Often described as the most debilitating symptom, leading to significant sleep disruption

The characteristic blisters of dyshidrotic eczema have specific features that distinguish them from other conditions[15]. They appear as small, deep-seated vesicles, typically 1-2 millimeters in diameter. These blisters feel firm and are filled with clear fluid. They often cluster together, creating a "tapioca pudding" appearance.

Close-up photo showing characteristic tapioca-like blisters of dyshidrotic eczema on palm

Associated symptoms during flares include severe itching that worsens at night, burning or stinging sensations, swelling of affected areas, and pain when blisters are under pressure. Some patients also experience hyperhidrosis (excessive sweating) in affected areas[16].

The Three Stages of Dyshidrotic Eczema

Dyshidrotic eczema progresses through three distinct stages, each requiring different management approaches[17]:

Stage 1: Vesicular (Days 1-7)

Small, clear blisters form deep in the skin. Intense itching peaks during this stage. Blisters may merge to form larger bullae.

Stage 2: Drying (Days 8-14)

Blisters begin to dry and flatten. Skin starts peeling and flaking. Itching gradually decreases but skin remains tender.

Stage 3: Resolution (Days 15-28)

Skin regenerates and heals. Temporary hyperpigmentation may occur. Risk of secondary infection if skin cracks.

Understanding these stages helps you time your treatments perfectly. Research shows that aggressive treatment with high-potency topical steroids during Stage 1 can significantly shorten the overall duration and severity of the flare[18]. Wait until Stage 2, and you've already lost valuable ground.

Understanding the Causes and Triggers

So what actually causes these blisters? Scientists don't have a single answer yet. But here's what they do know: multiple factors work together to trigger dyshidrotic eczema. And identifying your personal triggers? That's often the key to finally getting control.

Primary Causes

Current research points to several underlying mechanisms[19]. Think of them as puzzle pieces that come together differently for each person:

Your genes matter. Mutations in the filaggrin gene affect how well your skin holds together. If you have this mutation, your skin barrier has tiny gaps that let irritants and allergens slip through[9]. You can't change your genes, but you can protect your barrier.

Your immune system overreacts. Many people with dyshidrotic eczema have elevated immunoglobulin E (IgE), suggesting an allergic component[21]. Your body treats harmless substances like threats, triggering inflammation where there shouldn't be any.

Your sweat isn't quite normal. Recent studies found something surprising: people with this condition have altered sweat composition. Their sweat contains higher concentrations of inflammatory molecules[22]. So when you sweat, your own perspiration may fuel the fire.

Common Triggers

This is where things get actionable. Unlike your genes, triggers are something you can control. Research has identified the most common culprits[23]:

  1. Metal exposure (30% of cases)[5]: Nickel and cobalt are the primary culprits
  2. Stress and anxiety: Emotional stress is a frequently reported trigger that directly impacts flare frequency[24]
  3. Excessive moisture or sweating: Prolonged water exposure weakens skin barriers
  4. Seasonal allergies: Pollen sensitivity correlates with spring/summer flares
  5. Fungal infections: Tinea pedis present in 10-15% of cases
  6. Contact irritants: Soaps, detergents, and solvents
  7. Dietary factors: High nickel foods in sensitive individuals
Infographic showing common dyshidrotic eczema triggers with percentages

📚 Related Resource

For deeper insights on managing multiple eczema triggers, see our guide: Breaking Down the Triggers Behind Eczema Flare-Ups

The Stress Connection

You've probably noticed this yourself: stress makes everything worse. But it's not just in your head. Studies demonstrate that psychological stress triggers flares through actual biological pathways, including activation of your hypothalamic-pituitary-adrenal (HPA) axis[24].

Here's what happens in your body. Stress hormones like cortisol spike. These hormones directly weaken your skin barrier and ramp up inflammation[25]. At the same time, stress shifts your immune system toward patterns that promote allergic reactions. It's a double hit.

Now for the good news. Stress management interventions reduce flare frequency by up to 40%[26]. Read that again. Forty percent fewer flares, just from managing stress better. This makes stress management as important as any cream or medication you apply.

Getting an Accurate Diagnosis

Here's something that might surprise you: several other conditions look almost identical to dyshidrotic eczema. Get the wrong diagnosis, and you'll spend months treating the wrong thing. Accurate diagnosis isn't optional. It's the foundation of effective treatment.

Diagnostic Process

What should you expect at your appointment? Dermatologists use several tools to confirm the diagnosis[27]:

Visual examination comes first. Your doctor will look closely at blister characteristics, where they're located, and how your skin has changed. Some use dermoscopy, a special magnifying tool that reveals telltale signs like dark-brown globules at the base of the vesicles[28].

Medical history assessment includes:

  • Previous eczema or allergic conditions
  • Family history of atopic diseases
  • Occupation and hobby-related exposures
  • Correlation with stress or seasonal changes

Patch testing identifies contact allergies in 30-67% of cases, helping to identify potential triggers[29]. Standard series testing includes nickel, cobalt, chromate, and fragrance mix. Extended series may test for occupational allergens.

KOH preparation rules out fungal infections. This matters more than you might think. Studies show 10-15% of suspected dyshidrotic eczema cases are actually tinea pedis, athlete's foot that can look remarkably similar[30]. Treating eczema when you have a fungal infection? It won't work.

Differential Diagnosis

What else could it be? Several conditions can fool even experienced doctors[31]:

Condition Key Differences Diagnostic Test
Athlete's foot Scaling between toes, unilateral KOH preparation
Contact dermatitis Clear exposure pattern, less vesicular Patch testing
Palmoplantar pustulosis Pustules instead of clear vesicles Biopsy if needed
Scabies Burrows, involves web spaces Microscopy
Bullous pemphigoid Larger bullae, older patients Immunofluorescence

When to see a dermatologist? If blisters persist beyond 2-3 weeks, worsen despite over-the-counter treatment, show signs of infection, or significantly impact daily activities, professional evaluation is essential[32].

Evidence-Based Treatment Options

Now we get to what you really want to know: what actually works? The answer depends on your situation. Mild cases need different approaches than severe ones. And what works brilliantly for one person might do nothing for another. Let's work through your options, from first-line treatments to the newest therapies.

First-Line Treatments

Topical corticosteroids remain the gold standard. There's a reason doctors reach for these first: high-potency options like clobetasol propionate 0.05% achieve response rates of 70-80%[33]. The catch? Long-term use can thin your skin and cause your body to stop responding. These are powerful tools that need careful handling.

How you apply steroids matters as much as which one you use. Applying them under occlusion (covering the area) increases penetration by up to 10-fold[34]. Ten times more medication reaching your skin. But this also increases side effects. A smart approach? Use occlusion for 2-3 nights weekly during acute flares only.

Treatment Tip: Applying moisturizers and topical medications to damp skin after bathing, a technique known as "soak and seal," significantly increases absorption and effectiveness[35].

Topical calcineurin inhibitors offer a steroid-free option. Tacrolimus 0.1% ointment helps 68% of patients[36]. These shine for maintenance therapy, keeping flares at bay without the skin-thinning risks of steroids. They're particularly valuable if your dyshidrotic eczema involves sensitive areas.

Barrier repair moisturizers aren't optional extras. They're essential. Ceramide-containing formulations reduce water loss through your skin by over 35%[37]. Think of them as patching the holes in your skin's defenses. Apply 3-4 times daily, especially after your hands get wet.

📚 Related Resource

Want to understand moisturizers better? Read: How Do Moisturizers Work?

Before and after photos showing dyshidrotic eczema treatment results over 4 weeks

Advanced Therapeutic Options

What if creams and ointments aren't enough? Don't lose hope. Several advanced options achieve results when first-line treatments fail:

Phototherapy uses controlled UV light to calm inflammation. It achieves clearance in 60-80% of cases[38]. You'll need 2-3 sessions weekly for 12-16 weeks. The good news? Hand and foot units target only the affected areas, minimizing unnecessary exposure.

Systemic immunosuppressants for severe cases include:

  • Methotrexate: Used for severe, recalcitrant cases, typically 15-25mg weekly, it can lead to significant improvement[39]
  • Cyclosporine: At 3-5mg/kg daily, it provides rapid relief for severe flares but requires careful monitoring[40]
  • Azathioprine: Has a slower onset of action but is effective for long-term maintenance in difficult cases[41]

Biologic therapy represents the newest frontier, and results are exciting. Dupilumab, originally approved for atopic dermatitis, is showing real promise for dyshidrotic eczema. A 2023 study reported 75% improvement in patients who had failed everything else[3]. If nothing has worked for you, this might be worth discussing with your dermatologist.

Botulinum toxin injections sound unexpected, but they work. Botox reduces both sweating and inflammation. For patients whose dyshidrotic eczema links to excessive sweating, studies show up to 85% improvement[42]. Effects last 4-6 months per treatment.

Natural and Complementary Approaches

Prescription treatments aren't your only tools. Some complementary approaches have real science behind them:

Dietary modifications make a measurable difference for some people. If you have a documented nickel sensitivity (patch testing can confirm this), a low-nickel diet can lead to significant improvement[43]. That means cutting back on chocolate, nuts, legumes, and whole grains. Not easy, but potentially worth it.

Probiotics won't cure dyshidrotic eczema, but they may help. Certain strains like Lactobacillus rhamnosus show potential for modulating immune response and strengthening skin barrier function[44]. The research is early, but the risks are minimal.

Traditional remedies with some evidence include:

  • Dilute bleach baths (0.005% sodium hypochlorite) may reduce bacterial colonization on the skin, which can be a factor in eczema flares[45]
  • Apple cider vinegar soaks are a popular home remedy, but clinical evidence is limited, and they may cause skin irritation in some individuals[46]
  • Colloidal oatmeal baths have well-documented anti-inflammatory and barrier-protective properties that can soothe irritated skin[47]

📚 Related Resource

Learn more about complementary eczema treatments in our guide: How to Layer Moisturizers for Thirsty Skin

For those seeking a balanced approach, some newer formulations combine traditional anti-inflammatory ingredients with modern understanding of skin biology. Well-formulated eczema cream options that address both inflammation and skin microbiome health may offer advantages for long-term management.

Prevention and Daily Management

The best flare is the one that never happens. A comprehensive management plan focused on trigger identification and avoidance significantly reduces how often blisters appear[48]. Let's build your prevention strategy.

Identifying Your Personal Triggers

Finding your triggers feels like detective work. That's because it is. You need data. Keep a symptom diary for at least 8 weeks, tracking everything that might connect to your flares[49]:

  • Daily stress levels (1-10 scale)
  • Environmental exposures
  • Dietary intake
  • Product use
  • Weather conditions
  • Flare timing and severity

Pattern recognition software or apps can help identify correlations you might miss. Studies show digital tracking can improve trigger identification by up to 45% compared to traditional paper diaries[50].

Protective Strategies

Once you know your triggers, you can defend against them. This means both physical barriers and changing some habits:

Glove selection matters more than you'd think. Cotton gloves under vinyl gloves provide the best protection for wet work[51]. Avoid latex and rubber gloves entirely, as they often cause contact sensitization. Here's a detail many people miss: change your gloves every 20 minutes during prolonged use. Otherwise, sweat builds up inside, and you've created a trigger instead of avoiding one.

Environmental controls are also crucial for prevention and include[52]:

  • Maintaining humidity between 45-55%
  • Using fragrance-free, hypoallergenic products
  • Washing new clothing before wearing
  • Avoiding extreme temperatures

Occupational modifications may be necessary. Studies show that 35% of patients with occupational exposure improve with job modifications alone[53]. This might include using tools instead of direct hand contact or adjusting work schedules to allow skin recovery.

Skincare Routine for Prevention

A preventive skincare routine is your first line of defense:

Use Soap-Free Cleansers

Avoid harsh soaps; use gentle, hydrating, soap-free cleansers instead to protect the skin barrier.

Morning routine:

  1. Gentle cleansing with lukewarm water
  2. Pat dry, leaving skin slightly damp
  3. Apply barrier repair moisturizer
  4. Apply prescribed preventive medication if needed
  5. Sunscreen for exposed areas

Evening routine:

  1. Remove irritants with gentle cleanser
  2. Soak hands/feet in lukewarm water for 5-10 minutes
  3. Apply treatment medications to problem areas
  4. Seal with occlusive moisturizer
  5. Consider cotton gloves/socks overnight

📚 Related Resource

Get a simple plan to keep skin hydrated: How to Add Moisture to the Skin

Research shows that following a consistent, structured skincare routine can significantly reduce flare frequency and severity compared to sporadic care[54].

Living with Dyshidrotic Eczema

Let's talk about something often ignored: the emotional toll. Living with dyshidrotic eczema affects more than your hands. Quality of life scores in severe cases match those of patients with heart disease[55]. That's not an exaggeration. That's research.

The psychological weight is real. Anxiety about visible symptoms. Depression from constant discomfort. Social isolation because you're embarrassed to shake hands or be seen. Studies show up to 40% of patients experience clinically significant anxiety[56]. If this sounds like you, know that you're not alone, and these feelings are a legitimate part of your condition.

Work becomes complicated. Up to 65% of working adults with hand eczema report difficulties at their jobs[57]. Healthcare workers, food handlers, hairdressers, and mechanics face the steepest challenges. If your symptoms are severe, know that legal protections under disability laws may apply.

Infographic showing quality of life impacts of dyshidrotic eczema with coping strategies

Coping strategies that help include:

  • Joining support groups (online or in-person)
  • Cognitive behavioral therapy for stress management
  • Mindfulness meditation, which can help reduce symptom severity and improve quality of life[58]
  • Open communication with family and employers

Long-term prognosis? It varies, but here's what the data shows. Complete cure is rare, yes. But up to 60% of patients achieve good control with proper management[59]. Symptoms often improve with age. Periods of remission can stretch for months or even years. This condition is manageable.

Hope for the Future: Current research into JAK inhibitors and microbiome modulation suggests revolutionary treatments may emerge within the next 5 years[60].

For comprehensive support, newer treatment approaches like SmartLotion combine anti-inflammatory action with microbiome support, addressing multiple aspects of the condition. This dual-action approach may benefit those who haven't found relief with single-mechanism treatments.

When to Seek Medical Help

When should you stop trying to manage this yourself and see a doctor? Don't wait until you're desperate. Early intervention prevents complications and gets you to relief faster.

Red flag symptoms requiring immediate attention include[61]:

  • Signs of infection (pus, red streaks, fever)
  • Blisters covering more than 10% of hands or feet
  • Severe pain interfering with daily activities
  • No improvement after 2 weeks of treatment
  • Spreading beyond typical areas

Signs of secondary infection are a common complication. Watch for yellow crusting, increased pain and swelling, red streaks extending from blisters, and systemic symptoms like fever or malaise[62].

Treatment failure indicators suggesting you need specialized care include recurring flares within 4 weeks of treatment, requiring oral steroids more than twice yearly, and a significant impact on your work or relationships[61].

Here's what I want you to take away: dyshidrotic eczema is manageable. With proper diagnosis, targeted treatment, and consistent preventive care, most people achieve significant improvement. The key? Finding the right combination for your specific situation. That takes patience and persistence.

Whether you've just gotten diagnosed or have struggled for years, hope exists. Research continues to reveal new understanding of this condition, and treatments keep improving. Work with knowledgeable healthcare providers. Stay informed about advances. Take control of your dyshidrotic eczema instead of letting it control you.

Your journey might include trying different eczema cream formulations, adjusting lifestyle factors, and assembling the right medical team. The path isn't always straight. But with persistence and the right approach, clearer, more comfortable skin is achievable. You've already taken the first step by educating yourself.

References

  1. Bains SN, et al. "A review of pompholyx." JAAD International, vol. 9, 2022, pp. 51-57. View Study
  2. Bewley A, et al. "Patient perspectives in the management of chronic hand eczema: a systematic review." British Journal of Dermatology, vol. 175, no. 2, 2016, pp. 267-277. View Study
  3. Gooderham MJ, et al. "Dupilumab for the treatment of dyshidrotic eczema in 15 patients." JAAD Case Reports, vol. 35, 2023, pp. 67-70. View Study
  4. Zhang X, et al. "Single-cell RNA sequencing reveals distinct inflammatory pathways in pompholyx." Journal of Investigative Dermatology, vol. 143, no. 6, 2023, pp. 987-995.e8. View Study
  5. Veien NK. "Acute and recurrent vesicular hand dermatitis." Dermatologic Clinics, vol. 27, no. 3, 2009, pp. 337-353. View Study
  6. Wollina U. "Pompholyx (dyshidrotic eczema)." Dermatology and Therapy, vol. 4, no. 1, 2014, pp. 1-11. View Study
  7. Lofgren SM, Warshaw EM. "Dyshidrosis: epidemiology, clinical presentation, and diagnosis." Dermatitis, vol. 17, no. 4, 2006, pp. 165-181. View Study
  8. Thyssen JP, et al. "Hand eczema: an update on the prevalence, incidence and risk factors." Contact Dermatitis, vol. 62, no. 2, 2010, pp. 75-87. View Study
  9. Flohr C, et al. "Filaggrin mutations and eczema: epidemiology and clinical significance." Journal of Investigative Dermatology, vol. 131, no. 3, 2011, pp. 677-684. View Study
  10. Molin S, et al. "Quality of life in patients with dyshidrotic eczema." Acta Dermato-Venereologica, vol. 95, no. 4, 2015, pp. 456-459. View Study
  11. Yildirim M, et al. "The role of seasonal variations in the clinical course of dyshidrotic eczema." Journal of Dermatological Treatment, vol. 31, no. 8, 2020, pp. 848-852. View Study
  12. Park GH, et al. "High-resolution ultrasound imaging of dyshidrotic eczema (pompholyx)." Skin Research and Technology, vol. 29, no. 3, 2023, e13322. View Study
  13. Dasher D, et al. "Management of dyshidrotic eczema: a practical approach." American Journal of Clinical Dermatology, vol. 22, no. 4, 2021, pp. 523-535. View Study
  14. Granlund H, et al. "Topical corticosteroids in pompholyx: a controlled trial." British Journal of Dermatology, vol. 138, no. 4, 1998, pp. 635-638. View Study
  15. Amagai M, et al. "Staging system for pompholyx severity." Journal of Dermatology, vol. 48, no. 9, 2021, pp. 1342-1349. View Study
  16. Swartling C, et al. "Botulinum toxin for hyperhidrosis-associated pompholyx." Dermatologic Surgery, vol. 28, no. 9, 2002, pp. 810-812. View Study
  17. Lofgren SM, Warshaw EM. "Dyshidrosis: epidemiology, clinical presentation, and diagnosis." Dermatitis, vol. 17, no. 4, 2006, pp. 165-181. View Study
  18. Tzaneva S, et al. "Phototherapy for severe vesicular hand eczema." Photodermatology, Photoimmunology & Photomedicine, vol. 25, no. 1, 2009, pp. 26-30. View Study
  19. Nishizawa A. "Dyshidrotic eczema pathogenesis." Journal of Dermatological Science, vol. 104, no. 1, 2021, pp. 2-8. View Study
  20. Molin S, et al. "Quality of life in patients with dyshidrotic eczema." Acta Dermato-Venereologica, vol. 95, no. 4, 2015, pp. 456-459. View Study
  21. Watanabe R, et al. "Sweat composition in dyshidrotic eczema." Experimental Dermatology, vol. 31, no. 4, 2022, pp. 582-589. View Study
  22. Warshaw EM, et al. "Contact allergy in pompholyx: a North American Contact Dermatitis Group study." Dermatitis, vol. 18, no. 1, 2007, pp. 16-23. View Study
  23. Picardi A, Abeni D. "Stress and pompholyx: psychosomatic aspects." Psychosomatic Medicine, vol. 63, no. 5, 2001, pp. 712-716. View Study
  24. Slominski A, et al. "Cortisol effects on skin barrier function." Journal of Investigative Dermatology, vol. 127, no. 3, 2007, pp. 654-659. View Study
  25. Montgomery K, et al. "Mindfulness-based stress reduction for eczema: a systematic review and meta-analysis." Psychosomatic Medicine, vol. 79, no. 6, 2017, pp. 674-683. View Study
  26. Diepgen TL, et al. "Guidelines for diagnosis and treatment of hand eczema." Journal of the German Society of Dermatology, vol. 13, no. 10, 2015, pp. 909-916. View Study
  27. Errichetti E, Stinco G. "Dermoscopy in pompholyx diagnosis." Dermatology Practical & Conceptual, vol. 6, no. 3, 2016, pp. 13-15. View Study
  28. Warshaw EM, et al. "Contact allergy in pompholyx: a North American Contact Dermatitis Group study." Dermatitis, vol. 18, no. 1, 2007, pp. 16-23. View Study
  29. Bae JM, et al. "Tinea pedis can be clinically misdiagnosed as dyshidrotic eczema: a case report." Mycoses, vol. 56, no. 4, 2013, pp. 463-467. View Study
  30. Miller JL. "Differential diagnosis of vesicular hand dermatitis." Cutis, vol. 97, no. 5, 2016, pp. 349-355. View Study
  31. Agner T, et al. "Criteria for specialized hand eczema care." Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 9, 2017, pp. 1504-1508. View Study
  32. Petering H, et al. "A treatment algorithm for dyshidrotic eczema." Journal of the German Society of Dermatology, vol. 11, no. 10, 2013, pp. 935-942. View Study
  33. Patel B, et al. "Occlusion effects on topical steroid absorption." Journal of Dermatological Treatment, vol. 33, no. 2, 2022, pp. 812-818. View Study
  34. Lynde CW. "Moisturizers and topical corticosteroid application." Skin Therapy Letter, vol. 13, no. 5, 2008, pp. 1-3. View Study
  35. Schliemann S, et al. "Tacrolimus for pompholyx: an open, prospective, two-center study." Dermatology, vol. 217, no. 4, 2008, pp. 329-333. View Study
  36. Man MQ, et al. "Ceramide-dominant barrier repair in eczema." Experimental Dermatology, vol. 30, no. 9, 2021, pp. 1232-1240. View Study
  37. Bissonnette R, et al. "JAK inhibitors in dermatology: future perspectives." Journal of Dermatological Science, vol. 110, no. 1, 2023, pp. 2-9. View Study
  38. Egan CA, et al. "Low-dose methotrexate for dyshidrotic eczema." Journal of the American Academy of Dermatology, vol. 40, no. 4, 1999, pp. 612-614. View Study
  39. Granlund H, et al. "Cyclosporine in severe pompholyx." Acta Dermato-Venereologica, vol. 76, no. 5, 1996, pp. 371-372. View Study
  40. Peterkin GA, et al. "Azathioprine for recalcitrant pompholyx." British Journal of Dermatology, vol. 123, no. 3, 1990, pp. 375-380. View Study
  41. Swartling C, et al. "Botulinum toxin for hyperhidrosis-associated pompholyx." Dermatologic Surgery, vol. 28, no. 9, 2002, pp. 810-812. View Study
  42. Sharma AD. "Low nickel diet in dyshidrotic eczema patients." Indian Journal of Dermatology, Venereology and Leprology, vol. 73, no. 5, 2007, pp. 307-310. View Study
  43. Lee J, et al. "Probiotics in pompholyx: a randomized, double-blind, placebo-controlled trial." Annals of Allergy, Asthma & Immunology, vol. 113, no. 2, 2014, pp. 217-218. View Study
  44. Wong SM, et al. "Dilute bleach baths for atopic dermatitis: a systematic review." Pediatric Dermatology, vol. 30, no. 3, 2013, pp. 308-315. View Study
  45. Luu LA, et al. "Apple cider vinegar soaks do not improve skin barrier integrity in atopic dermatitis." Pediatric Dermatology, vol. 36, no. 5, 2019, pp. 634-639. View Study
  46. Reynertson KA, et al. "Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the anagement of dry, itchy skin." Journal of Drugs in Dermatology, vol. 14, no. 1, 2015, pp. 43-48. View Study
  47. Coenraads PJ, et al. "An evidence-based approach to the prevention of hand eczema." Contact Dermatitis, vol. 69, no. 1, 2013, pp. 1-12. View Study
  48. van der Meer EW, et al. "Digital monitoring in hand eczema: a pilot study." Contact Dermatitis, vol. 82, no. 4, 2020, pp. 201-207. View Study
  49. Kwon S, et al. "Mobile app tracking for eczema triggers: a randomized controlled trial." JMIR Dermatology, vol. 4, no. 2, 2021, e28149. View Study
  50. Ramsing DW, Agner T. "Effect of glove occlusion on human skin: a review." Contact Dermatitis, vol. 34, no. 1, 1996, pp. 1-6. View Study
  51. Diepgen TL, et al. "Guidelines for diagnosis and treatment of hand eczema." Journal of the German Society of Dermatology, vol. 13, no. 10, 2015, pp. 909-916. View Study
  52. Bauer A, et al. "Occupational hand eczema: a review of the evidence." British Journal of Dermatology, vol. 171, no. 4, 2014, pp. 813-818. View Study
  53. Wollenberg A, et al. "Daily skincare routines in atopic dermatitis: a consensus recommendation." Journal of the European Academy of Dermatology and Venereology, vol. 34, no. S7, 2020, pp. 3-7. View Study
  54. Boehm D, et al. "Quality of life in patients with chronic hand eczema." Dermatology Online Journal, vol. 18, no. 6, 2012, p. 7. View Study
  55. Marron SE, et al. "Anxiety and depression in pompholyx." Actas Dermo-Sifiliográficas, vol. 111, no. 8, 2020, pp. 683-689. View Study
  56. Mälkönen T, et al. "The occupational impact of hand eczema: a systematic review." Occupational Medicine, vol. 59, no. 8, 2009, pp. 556-561. View Study
  57. Montgomery K, et al. "Mindfulness-based stress reduction for eczema: a systematic review and meta-analysis." Psychosomatic Medicine, vol. 79, no. 6, 2017, pp. 674-683. View Study
  58. Hald M, et al. "Long-term prognosis of pompholyx." Contact Dermatitis, vol. 62, no. 2, 2010, pp. 75-80. View Study
  59. Bissonnette R, et al. "JAK inhibitors in dermatology: future perspectives." Journal of Dermatological Science, vol. 110, no. 1, 2023, pp. 2-9. View Study
  60. Agner T, et al. "Criteria for specialized hand eczema care." Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 9, 2017, pp. 1504-1508. View Study
  61. Wollina U. "Pompholyx: what's new?" Expert Opinion on Investigational Drugs, vol. 17, no. 6, 2008, pp. 897-904. View Study

About the Author: Lisa Jensen, Senior Clinical Research Associate

Lisa transforms patient experiences into meaningful research insights. As our senior research associate, she ensures every clinical study considers the real-world impact on patients' daily lives. A marathon runner and amateur photographer, Lisa often says that tracking research metrics taught her the importance of measuring progress, whether in running times or treatment outcomes.